cdmo.directory
← Compare landing

Cellab CDMO vs Hillgene

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cellab/hillgene

CategoryCellab CDMOHillgene
Listed sitecdmocdmo
SummaryCell and gene therapy CDMO providing cell banking, GMP manufacturing, cryopreservation and EU QP batch release for clinical-stage ATMPs. Operates a 1,000 m² facility with four Grade B and one Grade C cleanroom plus an AABB-accredited cell bank.Hillgene is a leading CDMO provider specializing in cell therapy manufacturing, offering end-to-end solutions for CAR-T, TCR-T, CAR-NK, and UCAR-T cell therapies with GMP facilities in Suzhou and Belgium.
Services
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Process Development
  • Quality Control Testing
  • Cold-Chain Storage & Logistics
  • CMC Regulatory Submission Support
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Lentiviral Vector Manufacturing
  • mRNA Manufacturing
  • Quality Control Testing
  • Regulatory Affairs
  • CMC Regulatory Submission Support
Modalities
  • Cell Therapy
  • Gene Therapy
  • Cell Therapy
  • mRNA
  • Gene Therapy
IndicationsData not yet provided.
  • Oncology
  • Immunology
Locations
  • Sant Julià de Lòria, Sant Julià de Lòria, Sant Julià de Lòria, Andorra
  • Headquarters, Suzhou, Jiangsu, China
  • R&D Center, Suzhou, Jiangsu, China
  • GMP Facility, Belgium, Belgium
CertificationsData not yet provided.
  • FDA · Identifier: DMF filing approval for genetically modified K562 feeder cells
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.